Physical Pharmacy and Formulation
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
This section is intended to rapidly publish all aspects of current issues in physicochemical characterization of drug substances including proteins, and their formulation design and products development. An example of specific topics includes but not limited to:
Physical Pharmacy
- Solubility
- Solubilization
- Dissolution
- Polymorphism
- Permeability
- Stability and stabilization
- New materials for controlling drug characteristics
- Analytical techniques
Formulation
- Novel excipients
- Formulation science
- Drug delivery systems
- Controlled release
- Drug targeting
- Bioavailability
- Quality-by-design
- Regulatory science
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Excipients in the Design and Development of Pharmaceutical Formulations (Deadline: 31 May 2026)
- Nanotechnology in Formulation of Tumor-Targeted Drug Delivery Systems (Deadline: 31 May 2026)
- Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines, 2nd Edition (Deadline: 31 May 2026)
- Development of Skin Barrier Repair Therapy Formulations for Skin Care Purposes (Deadline: 31 May 2026)
- A New Generation of Metal Anticancer Drugs (Deadline: 30 June 2026)
- New Insights into Vaccine Adjuvants (Deadline: 30 June 2026)
- Emerging Drugs and Formulations for Pain Treatment (Deadline: 30 June 2026)
- Advances in Amorphous Solid Dispersions (Deadline: 20 July 2026)
- Dosage Form Design and Delivery Therapy for Skin Disorders (Deadline: 30 July 2026)
- Mucosal Drug Delivery: Exploring Novel Approaches and Formulations (Deadline: 31 July 2026)
- Exploring the Versatility of Cyclodextrins in Pharmaceutical Formulations (Deadline: 31 July 2026)
- Recent Advances in 3D Printing of Pharmaceutical Dosage Forms (Deadline: 31 July 2026)
- Drug Stability in Oral Administration (Deadline: 31 July 2026)
- Paediatric and Neonatal Specific Dosage Forms and Administration (Deadline: 31 July 2026)
- Amorphous Formulations and Solid-State Strategies to Improve Oral Drug Performance: Bridging Enabling Technologies, Biopharmaceutics, and Patient-Centric Product Design (Deadline: 31 July 2026)
- Drug Formulations Based on Chitosan and Its Derivatives for Therapeutic Applications (Deadline: 31 July 2026)
- Novel Formulation Strategies to Overcome Biological Barrier Permeability Challenges (Deadline: 31 August 2026)
- Natural Product-Based Pharmaceutical Formulations for Skin Drug Delivery (Deadline: 31 August 2026)
- Engineering Solid-State Properties of Active Pharmaceutical Ingredients (Deadline: 31 August 2026)
- Recent Advances in Cocrystal and Nano-Cocrystal Technologies for Pharmaceutical and Nutraceutical Applications (Deadline: 31 August 2026)
- Phytocompounds-Based Formulations for Anti-Inflammatory Disorders (Deadline: 31 August 2026)
- Innovative Approaches in Skin Formulation Development and Characterization: Scientific Foundations for Regulatory Transformation (Deadline: 31 August 2026)
- Pharmacy Compounding of Personalized Preparation for Specific Patients: Challenges and Advantages, 2nd Edition (Deadline: 10 September 2026)
- Precision Local Drug Delivery: From Formulation Design to Local Bioavailability Assessment (Deadline: 30 September 2026)
- Molecular Strategies to Enhance Drug Solubility (Deadline: 30 September 2026)
- Advances and Challenges in Nasal Formulation Developments, 3rd Edition (Deadline: 30 September 2026)
- Emerging Strategies to Enhance Solubility of Poorly Soluble Drugs: From Nanosystems to Molecular Innovations (Deadline: 30 September 2026)
- New Perspectives in Hydrogel Design for Medicine and Biotechnology (Deadline: 30 September 2026)
- Application of Marine-Derived Polymers in Drug Dosage Forms (Deadline: 20 October 2026)
- Solid Dispersions for Drug Delivery: Development, Preparation and In Vitro/In Vivo Characterization, 2nd Edition (Deadline: 25 October 2026)
- Advances in Natural Anticancer Formulation (Deadline: 31 October 2026)
- Pharmaceutical Cocrystals: Design, Development, and Therapeutic Applications (Deadline: 31 October 2026)
- Stability of Medicines and Novel Approaches for Predicting Drug Stability, 2nd Edition (Deadline: 31 October 2026)
- Pharmaceutical Formulation and Stability of Natural Products (Deadline: 31 October 2026)
- Development and Optimization of Buccal Films Formulations (Deadline: 31 October 2026)
- Design and Evaluation of Pharmaceutical Co-Crystallization: Integration of Structural Analysis and Pharmacodynamic Assessment (Deadline: 30 November 2026)
- Surfactants and Amphiphiles as Key Components in Diverse Pharmaceutical and Biomedical Applications (Deadline: 30 November 2026)
- Quality by Design Approach in Formulation Development (Deadline: 30 November 2026)
- Phytochemicals and Bioactive Compound-Based Pharmaceutical Formulations in Health and Disease: From Mechanisms to Therapeutic Applications (Deadline: 30 November 2026)
- Recent Advances in Tumor Microenvironment Responsive Formulations and Delivery Systems for Anticancer Therapy (Deadline: 30 November 2026)
- Probiotics in Pharmaceutics: Exploring the Therapeutic Potential and Formulation Strategies (Deadline: 18 December 2026)
- Advances in Solid Dosage Forms for Pediatric Pharmacotherapy (Deadline: 31 December 2026)
- Advances in Pharmaceutical Cocrystal Design and Technological Applications (Deadline: 31 December 2026)
- Bridging Computational and Experimental Methods in the Assessment of Novel Drug Formulations (Deadline: 31 December 2026)
- Recent Advances in Pharmaceutical Formulation (Deadline: 31 December 2026)
- Pharmaceutical Solid Dosage Forms: Manufacturing, Design, Development, and Biomedical Applications (Deadline: 31 January 2027)
- Cutting-Edge Approaches to Smart Pharmaceutics and Vaccine Development (Deadline: 31 January 2027)
- Advancements in Tablet Formulation and Technological Innovations in Pharmaceutical Manufacturing (Deadline: 18 February 2027)
- Solid Dispersions for Oral Delivery: Materials, Technologies, Characterization, and Translation (Deadline: 25 March 2027)
